Labcorpvs.Natera
LH vs NTRA · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Natera is about 1.7× larger than Labcorp by market cap; year to date, Natera leads (+17.8% vs +10.3%).
Side by side
| LH | NTRA | |
|---|---|---|
| Market cap | $22.7B | $38.8B |
| Price | $276.81 | $269.95 |
| Today | −0.3% | −4.2% |
| Return YTD | +10.3% | +17.8% |
| Return 1Y | +9.1% | +65.2% |
| P/E | 24.1 | — |
| P/S | 1.6 | 15.5 |
| P/B | 2.6 | 21.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
LabcorpLH
One of the largest US clinical laboratory networks plus contract research.
Full LH profile →NateraNTRA
Molecular and genetic diagnostics across prenatal screening, oncology and transplantation.
Full NTRA profile →More comparisons in Diagnostics
See where LH and NTRA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →